- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:55 | MHRA becomes founding member of HealthAI Global Regulatory Network | ||
| 13:55 | J&J's Darzalex recommended by CHMP to treat smouldering multiple myeloma | ||
| 13:25 | EC approves argenx's subcutaneous Vyvgart for rare autoimmune disease CIPD | ||
| 13:25 | The value of Medscape Extend - redefining omnichannel engagement with physicians in Europe | ||
| Di | AstraZeneca/Daiichi Sankyo's Datroway granted FDA accelerated approval for lung cancer | ||
| Di | Eli Lilly shares promising phase 3 results for once-weekly insulin candidate efsitora alfa | ||
| Di | Innovation with intention: balancing scientific progress and patient-centricity in oncology | ||
| Mo | PMGroup and Visions4Health launch Excellence in Healthcare Partnerships Awards | ||
| Mo | Sanofi/Regeneron's Dupixent granted FDA approval for bullous pemphigoid | ||
| Mo | First NHS patient treated with CSL Behring's haemophilia B gene therapy Hemgenix | ||
| Mo | Mitigating barriers to recruitment and retention in early stage Alzheimer's trials | ||
| Fr | Boehringer's Spevigo recommended by NICE for generalised pustular psoriasis | ||
| Fr | Ventyx's investigational NLRP3 inhibitor shows promise in Parkinson's disease | ||
| Fr | GCI Health appoints Aneeb Sharif as EMEA head of policy | ||
| Fr | Communicating with HCPs through AI takes finesse, flexibility and the human touch | ||
| Do | Gilead Sciences' twice-yearly HIV PrEP drug Yeztugo granted FDA approval | ||
| Do | FDA approves CSL's Andembry to prevent hereditary angioedema attacks | ||
| Do | Galderma shares positive long-term data for Nemluvio in prurigo nodularis | ||
| Do | Maximising the potential of AI in pharma | ||
| Do | Local muscle, global impact | ||
| 18.06. | Eli Lilly to expand cardiovascular disease pipeline with $1.3bn Verve acquisition | ||
| 18.06. | FDA unveils new voucher programme to accelerate drug review process | ||
| 18.06. | AstraZeneca's Ultomiris shows promise in rare post-transplant complication | ||
| 18.06. | Achieving gender parity - designing clinical trials with women in mind | ||
| 17.06. | Roche to advance Parkinson's disease candidate into phase 3 development |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .